{
    "2020-08-26": [
        [
            {
                "time": "",
                "original_text": "华熙生物(688363)2020年中报点评：业绩修复中 护肤品引领高速增长",
                "features": {
                    "keywords": [
                        "华熙生物",
                        "中报",
                        "业绩修复",
                        "护肤品",
                        "高速增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技",
                        "护肤"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "华熙生物上半年实现营收9.47亿元 疫情冲击下业绩逆势增长",
                "features": {
                    "keywords": [
                        "华熙生物",
                        "上半年",
                        "营收",
                        "疫情",
                        "逆势增长"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华熙生物(688363)：功能性护肤持续爆发 销售费用大幅提升拖累业绩 盈利能力下降",
                "features": {
                    "keywords": [
                        "华熙生物",
                        "功能性护肤",
                        "销售费用",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技",
                        "护肤"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "社保基金持有科创板股清单：新建仓8股，增持3只",
                "features": {
                    "keywords": [
                        "社保基金",
                        "科创板",
                        "新建仓",
                        "增持"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "受益功能性护肤品业务，华熙生物2020年上半年营收同比增17.05%",
                "features": {
                    "keywords": [
                        "华熙生物",
                        "功能性护肤品",
                        "营收增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技",
                        "护肤"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【国信零售|中报点评】华熙生物：护肤品保持高增长，卡位优质赛道前景广阔",
                "features": {
                    "keywords": [
                        "华熙生物",
                        "护肤品",
                        "高增长",
                        "优质赛道",
                        "前景广阔"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技",
                        "护肤"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}